Top Markets
Coin of the day
Asensus Surgical, Inc. Asensus Surgical, Inc.

Asensus Surgical, Inc.

ASXC
Rang in Aktien #22069
Asensus Surgical, Inc., a medical technology enterprise established in 2006 and... Asensus Surgical, Inc., a medical technology enterprise established in 2006 and headquartered in Durham, North Carolina, focuses on the research, development, and commercialization of robotic medical devices. Its core mission is to elevate minimally invasive surgical procedures throughout the United States, Europe, and Asia through innovative robotic solutions. The company's unique approach involves digitally bridging the gap between surgeons and patients, thereby introducing a new paradigm of "Performance-Guided surgery." This system aims to equip surgeons with critical clinical intelligence, ensuring consistently superior patient outcomes and setting a higher benchmark for surgical standards. Key products include the Senhance Surgical system, a multi-port robotic platform that can maneuver up to four arms to precisely control surgical instruments and a camera during laparoscopic operations. Their product line also features a range of specialized instruments, such as 3mm diameter instruments, 3mm and 5mm hooks, and articulating tools. Additionally, they offer the Senhance ultrasonic system, an advanced energy device designed for accurate, controlled tissue ligation and division. The company, initially known as TransEnterix, Inc., officially rebranded to Asensus Surgical, Inc. in February 2021.
Aktienkurs
$0.3479
Zuletzt synchronisiert: 2024-08-21
Marktkapitalisierung
$94.92M
Veränderung (1 Tag)
0.64%
Veränderung (1 Jahr)
0.00%
Land
US
Handel Asensus Surgical, Inc. (ASXC)

Kategorie

Gewinn für Asensus Surgical, Inc. (ASXC)
Gewinn im Jun 2024 TTM: $-83.44M
Laut den aktuellen Finanzberichten von Asensus Surgical, Inc. betragen die aktuellen Gewinne des Unternehmens $-83.44M. Im Jahr 2022 erzielte das Unternehmen einen Gewinn von $-75.24M, ein Rückgang im Vergleich zu dem Gewinn im Jahr 2021, der $-62.24M betrug. Die auf dieser Seite angezeigten Gewinne sind die Gewinne vor Zinsen und Steuern, auch bekannt als EBIT.
Gewinnverlauf von Asensus Surgical, Inc. von 2000 bis 2026
Gewinn am Ende jedes Jahres
Jahr Gewinn ändert
2026 (TTM) $-83.44M 6.82%
2023 $-78.12M 3.82%
2022 $-75.24M 20.90%
2021 $-62.24M 2.32%
2020 $-60.83M -61.34%
2019 $-157.33M 141.47%
2018 $-65.15M -56.01%
2017 $-148.10M 18.00%
2016 $-125.50M 161.62%
2015 $-47.97M 27.41%
2014 $-37.65M 32.77%
2013 $-28.36M 83.84%
2012 $-15.43M 167.89%
2011 $-5.76M 8.58%
2010 $-5.30M 124.13%
2009 $-2.37M -54.37%
2008 $-5.19M 70.50%
2007 $-3.04M 1,390.69%
2006 $-204.00K -10.53%
2005 $-228.00K -48.65%
2004 $-444.00K -54.04%
2003 $-966.00K -82.05%
2002 $-5.38M -997.00%
2001 $600.00K -77.01%
2000 $2.61M 0.00%
Gewinn ähnlicher Unternehmen oder Konkurrenten
Unternehmen Gewinn Gewinnunterschied Land
$7.51B -9,101.35%
US
$5.15B -6,269.48%
US
$5.56B -6,766.83%
IE
$3.86B -4,727.11%
US
- -
DE